DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Efficacy of Therapy With the Spironolactone Pills Compared to Minoxidil Lotion in Female Pattern Hair Loss

Information source: University of British Columbia
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Female Pattern Hair Loss

Intervention: Spironolactone (Drug); Minoxidil (Drug)

Phase: Phase 2

Status: Recruiting

Sponsored by: University of British Columbia

Official(s) and/or principal investigator(s):
Jerry Shapiro, MD, Principal Investigator, Affiliation: University of British Columbia

Overall contact:
Andreas Finner, Phone: 604 875 4747, Email: andreas.finner@vch.ca

Summary

This study evaluates the efficacy of therapy with the anti-androgen spironolactone compared to topical minoxidil in female pattern hair loss.

Clinical Details

Official title: Efficacy of Therapy With the Anti-androgen Spironolactone Compared to Topical Minoxidil in Female Pattern Hair Loss

Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Primary outcome: hair density

Secondary outcome:

percentage of subjects who experience side effects

subject assessment of treatment effect

Eligibility

Minimum age: 18 Years. Maximum age: 75 Years. Gender(s): Female.

Criteria:

Inclusion Criteria:

- Subjects must be premenopausal women older than 18 with female pattern hair loss.

Exclusion Criteria:

- Androgen excess

- Other scalp or hair disorders

- Contraindications to spironolactone treatment, especially pregnancy, electrolyte

imbalances, history of breast cancer, or intake of interfering drugs

- Contraindications to minoxidil treatment, especially patients who are allergic to

this treatment or have a history of low blood pressure or irregular heart beats

Locations and Contacts

Andreas Finner, Phone: 604 875 4747, Email: andreas.finner@vch.ca

UBC Division of Dermatology, Hair Research and Treatment Centre, Vancouver, British Columbia V6G 1Y6, Canada; Recruiting
Andreas Finner, Phone: 604 875 4747
Jerry Shapiro, MD, Principal Investigator
Additional Information

Starting date: September 2005
Last updated: November 15, 2011

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017